KORU Medical Systems Inc
KRMD3.315USD
-0.165-4.74%
交易中 （美东）报价延迟15分钟
152.96M总市值
亏损市盈率 TTM
关于 KORU Medical Systems Inc 公司
KORU Medical Systems, Inc. 设计、制造和销售专有的便携式先进医疗设备，主要面向皮下药物输送市场。该公司专注于家庭和专业输液解决方案。其重点主要集中在机械输液产品 FREEDOM 输液系统上，其中包括 FREEDOM60 注射器驱动器、FreedomEdge 注射器驱动器、HIgH-Flo 皮下安全针头组和精密流速管。这些设备用于在家中和替代护理环境中进行输液。其输液设备作为一个系统协同工作，为患有慢性疾病（如原发性免疫缺陷病 (PIDD) 和慢性炎症性脱髓鞘性多发性神经病 (CIDP)）的患者提供救命疗法。FREEDOM 系统的运行压力低于电动容积泵，并在患者的皮下组织可以承受的压力和系统输送的压力之间保持平衡。
公司简介
公司代码KRMD
公司名称KORU Medical Systems Inc
上市日期Oct 27, 1993
CEOMs. Linda M. Tharby
员工数量80
证券类型Ordinary Share
年结日Oct 27
公司地址100 Corporate Drive
城市MAHWAH
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编07430
电话18454692042
网址https://www.korumedical.com/
公司代码KRMD
上市日期Oct 27, 1993
CEOMs. Linda M. Tharby
公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.09M
+16.34%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
87.60K
+5.02%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
84.97K
+5.19%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
84.61K
+5.21%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
37.77K
+12.47%
Adam Kalbermatten
Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.09M
+16.34%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
87.60K
+5.02%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
84.97K
+5.19%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
84.61K
+5.21%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
37.77K
+12.47%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
业务USD
名称
营收
占比
Domestic Core
6.93M
71.90%
International Core
2.43M
25.21%
Novel Therapies
278.45K
2.89%
地区USD
名称
营收
占比
Domestic
7.21M
74.79%
International
2.43M
25.21%
业务
地区
业务USD
名称
营收
占比
Domestic Core
6.93M
71.90%
International Core
2.43M
25.21%
Novel Therapies
278.45K
2.89%
股东统计
更新时间: 8月1日 周五
更新时间: 8月1日 周五
持股股东
股东类型
持股股东
持股股东
占比
Horton Capital Management LLC
12.73%
First Light Asset Management, LLC
10.22%
Topline Capital Management, LLC
8.28%
Tharby (Linda M)
4.53%
The Vanguard Group, Inc.
3.82%
Other
60.42%
持股股东
持股股东
占比
Horton Capital Management LLC
12.73%
First Light Asset Management, LLC
10.22%
Topline Capital Management, LLC
8.28%
Tharby (Linda M)
4.53%
The Vanguard Group, Inc.
3.82%
Other
60.42%
股东类型
持股股东
占比
Hedge Fund
25.85%
Investment Advisor/Hedge Fund
14.56%
Investment Advisor
9.44%
Individual Investor
7.65%
Research Firm
1.32%
Pension Fund
0.81%
Other
40.36%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
179
27.81M
60.29%
+1.08M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
2023Q3
138
32.73M
71.92%
-2.69M
2023Q2
140
33.07M
72.70%
-1.19M
2023Q1
149
31.99M
70.39%
-2.55M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Horton Capital Management LLC
5.87M
12.73%
-16.19K
-0.27%
Apr 02, 2025
First Light Asset Management, LLC
4.71M
10.22%
+259.46K
+5.82%
Apr 30, 2025
Topline Capital Management, LLC
3.82M
8.28%
-505.93K
-11.69%
Mar 31, 2025
Tharby (Linda M)
2.09M
4.53%
+293.63K
+16.34%
Apr 21, 2025
The Vanguard Group, Inc.
1.76M
3.82%
+6.48K
+0.37%
Mar 31, 2025
Meros Investment Management, LP
746.56K
1.62%
-18.99K
-2.48%
Mar 31, 2025
Millennium Management LLC
603.21K
1.31%
+319.50K
+112.62%
Mar 31, 2025
Archon Capital Management LLC
566.87K
1.23%
+377.97K
+200.09%
Mar 31, 2025
Manko (Joseph M JR)
517.20K
1.12%
--
--
Apr 02, 2025
Geode Capital Management, L.L.C.
495.27K
1.07%
+32.09K
+6.93%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Global X Russell 2000 Covered Call ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.03%
Global X Russell 2000 ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
Global X Russell 2000 Covered Call ETF
占比0%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0%
iShares Russell 2000 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
